BVMed Board Nails Nine Theses On Innovation, Demands Restructuring
This article was originally published in The Gray Sheet
Executive Summary
Germany's diagnosis-related group payment system focuses inordinately on the patient treatment process rather than the specific device used, according to the German Medical Technology Association (BVMed)
You may also be interested in...
Invasive Procedure Quotas To Be Established By German Hospital DRG System
German reimbursement authorities will establish minimum procedure quotas to ensure payment for hospitals performing orthopedic, PTCA catheter and coronary procedures, according to BVMed
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.